21.20.0
Производство фармацевтических препаратов
152
Общество с ограниченной или дополнительной ответственностью
03877
Агентство по развитию фармацевтической отрасли при Министерстве здравоохранения Республики Узбекистан
1730401
Республика Узбекистан, Ферганская область, Фергана
Stability rating:
Tax debt:
Is a large taxpayer:
Has a license:
Abuses the right to reduce VAT payable:
Is a resident of the IT Park:
Rating of participants in the electronic public procurement system:
Developer rating:
Included in the unified register of unscrupulous performers:
No data on participation in public procurement as a supplier or customer
Коротко о компании
AFROSIYOBFARM has been operating since 2018 in the "Производство фармацевтических препаратов" industry. The director is Baxodirov Bobur Baxtiyor O‘g‘li. The company belongs to the "Medium business" category. Its primary activity is "Производство фармацевтических препаратов". The company has 2 founders, one of whom owns a 70% stake. The company has 2 licenses, confirming the broad scope of permitted activities in "{{oked_name}}".. The company has no registered property., is included in 0, and has 40 similar companies, indicating a developed competitive market.
Stability rating:
Tax debt:
Is a large taxpayer:
Has a license:
Abuses the right to reduce VAT payable:
Is a resident of the IT Park:
Rating of participants in the electronic public procurement system:
Developer rating:
Included in the unified register of unscrupulous performers:
2
0
2
0
No data on real estate
No data on trademarks
Коротко о компании
AFROSIYOBFARM has been operating since 2018 in the "Производство фармацевтических препаратов" industry. The director is Baxodirov Bobur Baxtiyor O‘g‘li. The company belongs to the "Medium business" category. Its primary activity is "Производство фармацевтических препаратов". The company has 2 founders, one of whom owns a 70% stake. The company has 2 licenses, confirming the broad scope of permitted activities in "{{oked_name}}".. The company has no registered property., is included in 0, and has 40 similar companies, indicating a developed competitive market.